p63 immunostaining in destained bronchoscopic cytological specimens
- 7 March 2005
- journal article
- research article
- Published by Wiley in Diagnostic Cytopathology
- Vol. 32 (4) , 198-203
Abstract
The p53 homologous squamous stem-cell regulatory protein p63 is expressed in squamous carcinomas but is not characteristically detected in small-cell carcinomas (SCCs). A panel of thyroid transcription factor (TTF) 1 and p63 has been shown to be useful in distinguishing SCCs from poorly differentiated squamous carcinoma of the lung (PDSLC) in small biopsies and cytological cell blocks. Because tumor samples frequently are limited to cytological smears, we attempted to detect p63 in destained slides from a spectrum of pulmonary malignancies. Archival alcohol-fixed smears from 60 cases of cytologically diagnosed malignancies in bronchoscopically (n = 59) or fine-needle aspiration-obtained specimens (n = 1) were destained in acid alcohol, postfixed in 10% formalin, subjected to citrate-based antigen retrieval, and immunostained by exposure to anti-p63 monoclonal antibody 4A4, followed by reagents from a streptavidin-biotin immunoperoxidase kit, and diaminobenzidine as the chromogen. Postfixation in 10% formalin was found to be necessary for immunostaining. Normal ciliated and goblet cells were p63 negative, but reserve cells were p63 positive. All cases of squamous-cell carcinoma were positive for p63. Of 10 tumor samples originally diagnosed as SCC, only 6 samples were p63 negative and 4 samples exhibited positive staining. However, proper interpretation of the immunohistochemical (IHC) staining pattern and careful scrutiny of the cytological features and biopsy specimens in three of four cases led us to reclassify three cases into PDSLC. All adenocarcinomas (ACAs; n = 12), large-cell carcinomas (n = 4), and metastatic ACAs (n = 5) were p63 negative. Positive staining was seen in 9/16 tumors designated as non-SCCs; these tumors were not classified further into distinct histological categories. p63 staining in destained slides may be of value in facilitating the differential diagnosis between PDSLC and SCC. Criteria for conservative interpretation of results are discussed and include examination of reserve cells and ciliated cells on the same slide as internal positive and negative controls. Diagn. Cytopathol. 2005;32:198–203.Keywords
This publication has 18 references indexed in Scilit:
- p63 expression in assessment of bronchioloalveolar proliferations of the lungLaboratory Investigation, 2004
- Surgery in small‐cell lung carcinoma. Where is the rationale?Seminars in Surgical Oncology, 2003
- Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarrayVirchows Archiv, 2003
- p63 expression in normal skin and usual cutaneous carcinomasJournal of Cutaneous Pathology, 2002
- Naked nuclei revisited: p63 ImmunoexpressionDiagnostic Cytopathology, 2002
- p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?The Journal of Pathology, 2002
- Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disordersHuman Pathology, 2001
- Identification of a Basal/Reserve Cell Immunophenotype in Benign and Neoplastic Endometrium: A Study with the p53 Homologue p63Gynecologic Oncology, 2001
- Histological Typing of Lung and Pleural Tumours1999
- Chemotherapy of Lung CancerNew England Journal of Medicine, 1992